Patent details

EP2044960 Title: Phospholipid analogue for the in vivo diagnosis of cancers

Basic Information

Publication number:
EP2044960
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP080103211
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
Phospholipid analogue for the in vivo diagnosis of cancers
French Title of Invention:
Analogue phospholipidique pour le diagnostic in vivo de cancers
German Title of Invention:
Phospholipid-Analog für die in vivo Diagnose von Krebs
SPC Number:

Dates

Filing date:
02/03/2005
Grant date:
20/11/2013
EP Publication Date:
20/11/2013
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
08/04/2009
EP B1 Publication Date:
20/11/2013
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
02/03/2014
Expiration date:
02/03/2025
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
02/03/2005
 
 

Name:
Cellectar Inc.
Address:
3301 Agriculture Drive, Madison, WI 53716, United States (US)

Inventor

1

Name:
Weichert Jamey
Address:
United States (US)

2

Name:
Pinchuk Anatoly
Address:
United States (US)

3

Name:
Longino Marc
Address:
United States (US)

Priority

Priority Number:
521166 P
Priority Date:
02/03/2004
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 51/04;
Filing date Document type Number of pages